Frontiers | Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
Eculizumab Injection
Dosing & Infusion Instruction | Soliris® (eculizumab) HCP
Recommended dosage and schedule of eculizumab in patients with aHUS | Download Table
Eculizumab treatment in atypical hemolytic uremic syndrome: correlation between functional complement tests and drug levels,Journal of Nephrology - X-MOL
Eculizumab - wikidoc
Recommended dosage and schedule of eculizumab in patients with aHUS | Download Table
Soliris, INN-eculizumab
SOLIRIS® (eculizumab) HCP | Dosing
Eculizumab dosing optimization in HSCT patients with TMA. (A) Suggested... | Download Scientific Diagram
Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT - ScienceDirect
Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study - Passot - 2021 - British Journal of Clinical Pharmacology - Wiley Online Library
Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use | SpringerLink
Children | Free Full-Text | A Multicenter Study Evaluating the Discontinuation of Eculizumab Therapy in Children with Atypical Hemolytic Uremic Syndrome
CDEC FINAL RECOMMENDATION
Eculizumab dosing optimization in HSCT patients with TMA. (A) Suggested... | Download Scientific Diagram
Dosing & Infusion Instruction | Soliris® (eculizumab) HCP
Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report: Clinical Pharmacology: Advances and Applications: Vol 3
Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. - Abstract - Europe PMC
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation - ScienceDirect
ULTOMIRIS® (ravulizumab-cwvz) | Official Website
Eculizumab Injection
Role of Soluble C5b-9 (sC5b-9) in Dosing Adjustments of Anti-complement Therapy during Pregnancy in a Patient with History of Atypical Hemolytic Uremic Syndrome (aHUS) - ISTH Congress Abstracts
